Technology

NuScale Power Stock Bounces to $10 as Investors Eye SMR Commercialization Path

NuScale Power shares gained 4.5% to $10.00 on news of a new training center, but the company's first-quarter revenue of $565,000 and $46.7 million net loss keep focus on potential customer commitments.

Sarah Chen · · · 3 min read · 3 views
NuScale Power Stock Bounces to $10 as Investors Eye SMR Commercialization Path
Mentioned in this article
SMR $10.08 +5.33%

NuScale Power Corporation (NYSE: SMR) saw its stock rise 4.5% on Friday, trading at $10.00, as the company opened its 12th Energy Exploration Center at the University of Virginia's College at Wise. The stock moved between $9.67 and $10.31 during the session, reflecting ongoing investor interest in the small modular reactor (SMR) developer's long-term potential despite its current financial challenges.

The latest milestone, announced Wednesday, is a workforce development initiative rather than a commercial reactor order. The training centers use simulator technology to prepare students and future operators for SMR technology, which aims to offer smaller, modular nuclear reactors as an alternative to traditional gigawatt-scale plants. CEO John Hopkins described the opening as "an important step forward in the expansion of clean-energy workforce development."

While the announcement supports NuScale's long-term ecosystem, it does not directly contribute to near-term revenue or reactor sales. Investors are primarily focused on whether the company can convert its regulatory head start into binding commercial contracts. NuScale's key advantage remains its licensing position: the Nuclear Regulatory Commission issued standard design approval for its US460 SMR design in May 2025, allowing the design to be referenced in future license applications.

Financial Realities and Market Challenges

The stock's volatility reflects the company's financial backdrop. NuScale reported first-quarter revenue of just $565,000 and a net loss of $46.7 million. Net loss attributable to Class A common stockholders was $44.0 million, or 14 cents per share. The company ended the quarter with $341.1 million in cash and cash equivalents, $549.0 million in short-term investments, and no debt.

The bear case centers on NuScale being a pre-commercial revenue story with substantial capital needs. Its 10-Q reveals a $1.0 billion at-the-market (ATM) stock-sale program, with $962.1 million still eligible for sale as of March 31. Additionally, NuScale sold 22.36 million Class A shares after quarter-end for net proceeds of $213.5 million, which strengthens its cash position but dilutes existing shareholders.

Catalysts and Commercial Outlook

The bull case highlights NuScale's potential to secure contracts driven by demand from artificial intelligence, data centers, and industrial electrification. The most significant visible opportunity is the TVA-ENTRA1 plan to develop up to 6 gigawatts of NuScale-powered nuclear capacity across TVA's seven-state region. Under this structure, ENTRA1 would develop and own plants, selling electricity to TVA through power purchase agreements (PPAs), which are long-term contracts that make projects financeable. However, independent industry coverage notes that public timelines and cost analyses have not yet been disclosed.

NuScale's stock has faced significant pressure in 2026, falling 23% over the past month and 34.5% year to date, according to a Zacks report. The company's market value currently stands at approximately $3.19 billion.

Investment Considerations

For speculative investors, NuScale's NRC-approved design and potential opportunities with TVA, Romania, or data-center projects could yield significant returns if they materialize into commercial orders. However, for more cautious investors, the combination of minimal revenue, ongoing losses, potential dilution, and uncertain project timing suggests patience is warranted. The next major catalyst will not be another training center announcement but rather a firm reactor sale, PPA, or project-financing package that demonstrates NuScale's technology can move from approved design to commercial deployment.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →